Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Tax Assets Current Deferred Tax Assets Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

Utah Medical Products (UTMD) Current Leases (2022 - 2023)

Utah Medical Products has reported Current Leases over the past 2 years, most recently at $47000.0 for Q4 2023.

Quarterly results put Current Leases at $47000.0 for Q4 2023, down 12.96% from a year ago — trailing twelve months through Dec 2023 was $47000.0 (down 12.96% YoY), and the annual figure for FY2023 was $47000.0, down 12.96%.
Current Leases for Q4 2023 was $47000.0 at Utah Medical Products, down from $54000.0 in the prior quarter.
Over the last five years, Current Leases for UTMD hit a ceiling of $54000.0 in Q4 2022 and a floor of $47000.0 in Q4 2023.